Pranovo Biotech 10808-C02E 說(shuō)明書(shū)

世界*實(shí)驗(yàn)材料供應(yīng)商 Pranovo Biotech正式授權(quán)上海起發(fā)為其中國(guó)代理， Pranovo Biotech在一直是行業(yè)的*,一直為廣大科研客戶(hù)提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶(hù)帶來(lái)的產(chǎn)品，的服務(wù)，簽約 Pranovo Biotech就是為了給廣大科研客戶(hù)帶來(lái)更加完善的產(chǎn)品和服務(wù),您的滿(mǎn)意將是我們zui大的收獲

Pranovo Biotech中國(guó)代理, Pranovo Biotech上海代理，Pranovo Biotech 特約代理理，Pranovo Biotech廣東代理， Pranovo Biotech江蘇代理Pranovo Biotech湖北代理,Pranovo Biotech天津,Pranovo Biotech黑龍江代理,Pranovo Biotech內(nèi)蒙古代理,Pranovo Biotech吉林代理,Pranovo Biotech福建代理, Pranovo Biotech江蘇代理, Pranovo Biotech浙江代理, Pranovo Biotech四川代理,

Pranovo Biotech是一家不斷發(fā)展的生物技術(shù)公司，我們主要生產(chǎn)高度純化的重組蛋白/抗體，包括細(xì)胞因子，生長(zhǎng)因子，趨化因子，激素，酶，病毒抗原和許多其他重組蛋白，用于癌細(xì)胞因子相關(guān)產(chǎn)品的研究團(tuán)體，凋亡，內(nèi)分泌學(xué)，免疫學(xué)，神經(jīng)科學(xué)，蛋白酶和干細(xì)胞研究。

同時(shí)，我們提供廣泛的分子生物學(xué)服務(wù)，包括定制肽服務(wù)，范圍從抗原設(shè)計(jì)，固相合成，修飾和純化; 客戶(hù)抗體服務(wù)范圍從重組蛋白表達(dá)，肽設(shè)計(jì)和合成，多克隆和單克隆抗體生產(chǎn)，表達(dá)多克隆和單克隆抗體生產(chǎn)，親和純化，共軛，分離和免疫測(cè)定開(kāi)發(fā)。

制品：

•  
• 重組蛋白
• 抗體
  • 小鼠Mab抗體
  • 兔Mab抗體
  • 兔Pab抗體
  • 標(biāo)簽抗體
  • 二抗
  • 對(duì)照抗體
• 色譜介質(zhì)
• 酶和試劑盒

??Cynomolgus BCA-1/ BLC/ CXCL13 Protein (His Tag)

• Catalog: 10808-C02E

Please Choose:Application

Antibody Production; ELISA; Protein Array; Western Blot;

Size   1mg 

     50μg

Cynomolgus BCA-1/ BLC/ CXCL13 Protein (His Tag)

For Research Use Only

Synonym : 

BCA-1, BLC, CXCL13, C-X-C Motif Chemokine 13

Source:

Recombinant Cynomolgus BCA-1/ BLC/ CXCL13 Protein, Val 23 - Pro 109(NP_001028052.1) was expressed in E.coli cells.

Molecular Characterization:

Recombinant Cynomolgus BCA-1/ BLC/ CXCL13 Protein, with a 6*His tag at the N-terminus, consists of 103 amino acids and has a calculated molecular mass of 12.4 kDa. The apparent molecular mass of Recombinant Cynomolgus BCA-1/ BLC/ CXCL13 Protein is approximay 14 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Sequence:

Cynomolgus BCA-1/ BLC/ CXCL13 Protein (His Tag)

Endotoxin:

<1.0 EU per μg of the Recombinant Cynomolgus BCA-1/ BLC/ CXCL13 Protein by the LAL method.

Purity:

>90% as determined by SDS-PAGE.

SDS-PAGE:

Formulation:

Lyophilized from sterile 10 mM Tris, 250mM  NaCl, pH 8.0

Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.

Contact us for customized product format or formulation.

Storage:

Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at:

• 4-8℃ for 1 year in lyophilized state

• 4-8℃ for 1 month under sterile conditions after reconstitution

• -20℃ to -70℃ for 3 months under sterile conditions after reconstitution

Reconstitution:

Reconstitution instruction will be sent along with the products. Please refer to it for detailed information.

Background:

Cynomolgus CXCL13, also known as BCA-1 ( B-cell-attracting chemokine-1 ) or BLC ( B-lymphocyte chemoattractant ), is a major regulator of B-cell trafficking. BCA-1/ BLC/ CXCL13 Protein is a small cytokine belonging to the CXC chemokine family. BCA-1/ BLC/ CXCL13 and its receptor CXCR5 control the organization of B cells within follicles of lymphoid tissues. BCA-1/ BLC/ CXCL13 Protein is known to dictate homing and motility of B cells in lymphoid tissue and has been implicated in the formation of ectopic lymphoid tissue in chronic inflammation. The increased level of BCA-1/ BLC/ CXCL13 Protein is a feature of systemic lupus erythematosus (SLE) that correlates with disease activity. Furthermore, BCA-1/ BLC/ CXCL13 Protein might be a readily available surrogate marker to monitor the extent of aberrant B-cell (dys-)function. The vascular endothelial BCA-1/ BLC/ CXCL13 Protein expression may be consequent to transcytosis. In Primary central nervous system lymphoma (PCNSL), expression of BCA-1/ BLC/ CXCL13 Protein by malignant lymphocytes and vascular endothelium may influence tumor development and localization to central nervous system (CNS). BCA-1/ BLC/ CXCL13 Protein expression is a distinctive feature of angioimmunoblastic T-cell lymphoma, providing further support for the germinal center T-helper cell as the cell of origin for this neoplasm. Furthermore, BCA-1/ BLC/ CXCL13 Protein, a chemokine that may participate in tumor pathogenesis and is a potential target for novel therapies.

我們公司zui大優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，

1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，

2：貨品全，現(xiàn)經(jīng)營(yíng)過(guò)700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，

3：提供加急服務(wù)，一般1-2周到貨，超過(guò)時(shí)限加急費(fèi)全免

4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽](méi)有服務(wù).

5：良好的信譽(yù)，大部分客戶(hù)我們提供貨到付款服務(wù)，客戶(hù)包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥 ，fisher等500多家公司

6：我們*代理的品牌有：Antibody Research Corporation，arcticzymes，Biorelevant，AmberGen, Inc. ，clemente-associates，clodronaiposomes，Columbia Biosciences，enzyme research，Gene Bridges GmbH，Genovis，AmberGen, Inc.  Biotechnology GmbH，Haematologic Technologies HTI Haemtech，hookelabs，Immudex，Innovative Research of America，inspiralis ，List Biological Laboratories, Inc.，lumafluor，Microsurfaces，multiplicom，nanotools，Pel-Freez Biologicals，pentapharm，progen，Protein Ark，QA-Bio,Inc，QA-Bio,IncQuickZyme Biosciences，Teknova，TriLink BioTechnologies, Inc.，Zyagen Laboratories 等

7：我們還是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知名*批發(fā)，歡迎合作。